Individual, expected diameters of the ascending aorta and prevalence of dilations in a study-population aged 60-74 years:a DANCAVAS substudy

Autor: Jes S. Lindholt, Flemming Hald Steffensen, Marek Karon, Oke Gerke, Jess Lambrechtsen, Axel Cosmus Pyndt Diederichsen, Tina H Leetmaa, Martin Busk, Jordi S. Dahl, Jacob E. Møller, Grazina Urbonaviciene, Kenneth Egstrup, Lasse M Obel, Lars Frost

Publikováno v: Obel, L M, Lindholt, J S, Leetmaa, T H, Dahl, J S, Møller, J E, Steffensen, F H, Frost, L, Lambrechtsen, J, Busk, M, Urbonaviciene, G, Egstrup, K, Karon, M, Gerke, O & Diederichsen, A C P 2021, ' Individual, expected diameters of the ascending aorta and prevalence of dilations in a study-population aged 60-74 years : a DANCAVAS substudy ', The international journal of cardiovascular imaging, vol. 37, no. 3, pp. 971-980 . https://doi.org/10.1007/s10554-020-02081-3

To determine individual, expected normal diameters of the ascending aorta (AAo) and prevalence of dilations based upon an absolute cut-off point (≥ 40 mm) and individual cut-off point (≥ 25% than expected normal). Non-contrast computed tomography

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac0de4fa7aa3968c4b5709848743be16
https://pure.au.dk/portal/da/publications/individual-expected-diameters-of-the-ascending-aorta-and-prevalence-of-dilations-in-a-studypopulation-aged-6074years(54b54a9d-92ee-44e5-80a0-87c3d5142d98).html

Are there long-term benefits in following stable heart failure patients in a heart failure clinic?

Autor: Torben Haghfelt, Henrik Villadsen, Lars Videbæk, Kirsten Vilain Mikkelsen, Tina H Leetmaa, Flemming Davidsen

Publikováno v: Leetmaa, T, Villadsen, H, Mikkelsen, K, Davidsen, F, Haghfelt, T & Videbæk, L 2008, ' Are there long-term benefits in following stable heart failure patients in a heart failure clinic? ', Scandinavian Cardiovascular Journal, pp. 1-6 . https://doi.org/10.1080/14017430802593443

Udgivelsesdato: 2008-Dec-8 Objectives and Design. This study describes the long-term outcome of 163 patients with stable mild to moderate heart failure (NYHA II-III), who already were enrolled in a heart failure clinic and now were randomized to cont

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b87f599d87ad781d4f8280a0a2adfdd3
https://pubmed.ncbi.nlm.nih.gov/19065446

[Dilated cardiomyopathy as a side effect of treatment with infliximab]

Autor: Tina H, Leetmaa, John D, Markenvard

Publikováno v: Ugeskrift for laeger. 167(39)

We report a case of heart failure after infusion of Remicade (infliximab) in a patient without heart insufficiency. The patient, a 25-year-old woman with inflammatory bowel disease, developed new-onset heart failure after receiving TNF antagonist the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::412a2976c8a4293129bcab2d650ee377
https://pubmed.ncbi.nlm.nih.gov/16219221